Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Acute Lymphatic Leukemia Induction Age: Adult |
Dose: by mouth – 2.5 mg/kg or 100-200 mg Frequency: once daily Note: Other agents preferred. May increase by 5 mg/kg/day after 4 weeks. Reduce dose by 75% if concomitant allopurinol administration. |
|
Indication: Acute Lymphatic Leukemia Maintenance Age: Adult |
Dose: by mouth – 1.5-2.5 mg/kg Frequency: once daily Note: Reduce dose by 75% if concomitant allopurinol administration. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Acute Lymphatic Leukemia Age: Child Condition: Starting dose |
Dose: by mouth (oral) – 1.25-2.5 mg/kg (50-75 mg/m²) Frequency: once daily |
|
Indication: Acute Lymphatic Leukemia Age: Child Condition: Maintenance |
Dose: by mouth (oral) – 1.5-2.5 mg/kg Frequency: once daily Note: in combination with methotrexate |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment |
Dose: Not specified Note: Dosage may need to be reduced. |
Administration
- Take on an empty stomach
- Take 1 hour before or 2 hours after meals
Side Effect
- Elevated LFT's (15%)
- Nausea (10%)
- Vomiting (10%)
- Stomatitis (3-10%)
- Thrombocytopenia (3-10%)
- Rash (1-3%)
- Diarrhea (1-3%)
- Dizziness (1-3%)
- Alopecia (1-3%)
- Leukopenia (1-3%)
- Fatigue
- Anorexia
- Headache
- Chills and fever
- Chest pain
- Mucositis
- Upper respiratory infection
- Cough
- Ulceration of intestine
- Ulcerative stomatitis
- Myelosuppressionm
- Decreased hematocrit
- Hepatotoxicity
- Decreased resistance to infections
- Hyperuricemia
- Nephrotoxicity
- Increased risk of pancreatitis in pts with IBD
- Hyperpigmentation of skin
- Arthralgias
- Eye discomfort
- Tinnitus
- Myelosuppression
- hepatotoxicity
- cholestatic jaundice
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Warfarin
|
Anticoagulant action may be inhibited
|
|
Myelosuppressive drugs
|
Enhanced toxicity
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Prior Resistance to Mercaptopurine/Thioguanine
|
Leads to treatment failure
|
|
Severe Liver Disease
|
Can worsen liver function
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at 20-25° C
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.